Medicines regulatory news
Periodic fees and cancellation of licences
Holders of authorisations, registrations and licences are required to notify the MHRA by 31 December 2012 to cancel authorisations, registrations and licences from 31 March 2013. If you have not cancelled them yet please do so as soon as possible.
This will ensure that you are not liable for a periodic fee in connection with a specific licence for the fee period 1 April 2013 to 31 March 2014.
Regulation 33 (5) (a) of the Medicines (Products for Human Use) (Fees) Regulations 2012 SI 2012 No.504 requires authorisation, registration or licence holders to give three months’ notice to the Licensing Authority before the beginning of a fee period (i.e. 1 April) if they wish to cancel a licence. They will then not be liable for the periodic fee.